EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell therapies for viral diseases: a new frontier

David Nardo, Emileigh G Maddox, James L Riley

Seminars in Immunopathology · 2025-12 · 47 (1)

DOI: 10.1007/s00281-024-01031-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 02.01.2025. Verfasst von David Nardo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, 19104, USA. Hauptthemen laut MEDLINE: Virus Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in medicine and antimicrobial research, viral infections continue to pose a major threat to human health. While major strides have been made in generating vaccines and small molecules to combat emerging pathogens, new modalities of treatment are warranted in diseases where there is a lack of treatment options, or where treatment cannot fully eradicate pathogens, as in HIV infection. Cellular therapies, some of which are FDA approved for treating cancer, take advantage of our developing understanding of the immune system, and harness this knowledge to enhance, or direct, immune responses toward infectious agents. As with cancer, viruses that evade immunity, do so by avoiding immune recognition or by redirecting the cellular responses that would eradicate them. As such, infusing virus specific immune cells has the potential to improve patient outcomes and should be investigated as a potential tool in the arsenal to fight infection. The present manuscript summarizes key findings made using cellular therapies for the treatment of viral infections, focusing on the potential that these strategies might have in controlling disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus DiseasesHumansAnimalsCell- and Tissue-Based Therapy

Stichwörter der Autor:innen

CAR T cellsMesenchymal stem cells (MSC)Virus specific T cells (VST)

Autor:innen und Institutionen

  • Department of Microbiology and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, 19104, USA.
  • Department of Microbiology and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, 19104, USA. rileyj@upenn.edu.

Förderung

  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Nardo, D., Maddox, E. G., & Riley, J. L. (2025). Cell therapies for viral diseases: a new frontier. Seminars in Immunopathology, 47(1). https://doi.org/10.1007/s00281-024-01031-8

Vancouver

Nardo D, Maddox EG, Riley JL. Cell therapies for viral diseases: a new frontier. Seminars in Immunopathology. 2025;47(1). doi:10.1007/s00281-024-01031-8

BibTeX
@article{Nardo2025,
  author = {Nardo, David and Maddox, Emileigh G and Riley, James L},
  title = {Cell therapies for viral diseases: a new frontier},
  journal = {Seminars in Immunopathology},
  year = {2025},
  volume = {47},
  number = {1},
  doi = {10.1007/s00281-024-01031-8}
}
Kostenlos starten →